Kruskall M S, Alper C A, Awdeh Z, Yunis E J, Marcus-Bagley D
Center for Blood Research, Boston, Massachusetts 02115.
J Exp Med. 1992 Feb 1;175(2):495-502. doi: 10.1084/jem.175.2.495.
We have recently shown that the human antibody response to the hepatitis B virus surface antigen (HBsAg) vaccine is major histocompatibility complex (MHC) associated. In studies of nonresponders to the vaccine, we found an increased incidence of individuals homozygous for human histocompatibility leukocyte antigen (HLA) proteins associated with the extended (conserved) haplotype [HLA-B8,SC01,DR3]. In later prospective vaccination trials, we showed that none of five individuals homozygous for this haplotype developed more than 1,300 radioimmunoassay (RIA) units of antibody (mean, 467 RIA units), while all heterozygotes made at least 2,500 RIA units (mean antibody level, 15,608 units). Our results suggested that [HLA-B8,SC01,DR3] lacks an immune response gene for HBsAg, and that response is inherited in a dominant fashion. To provide further evidence for this hypothesis, we have now analyzed the results of HBsAg immunization in families. 43 members of 10 families were immunized with the hepatitis B vaccine, including seven families where at least one member bore the haplotype [HLA-B8,SC01,DR3], and three families where one member had already received, but failed to respond to, the vaccine. In two of these three families, the presence of [HLA-B8,SC01,DR3] was subsequently found. Of nine MHC-identical sibling pairs in the study, both members of eight pairs had similar antibody responses (five nonresponder and three responder pairs). In all families with such sibling pairs, including the discordant pair, rank-ordering members by antibody level demonstrated that no relative's value came between the sibling pair values. Furthermore, of nine [HLA-B8,SC01,DR3]-haplotype-homozygous individuals, six were nonresponders, and two others had only low-normal responses. [HLA-B8,SC01,DR3]-heterozygous family members always had higher levels of antibody than their homozygous relatives. Linkage analysis of nonresponse to HLA haplotypes revealed a maximum likelihood LOD (logarithm of the odds) score of 6.3 at a recombination fraction of 0.1. The MHC association with lack of antibody response to HBsAg was not seen with tetanus immunization, where 1 of 20 HBsAg responders and 1 of 21 poor or nonresponders had tetanus titers of less than 1:512; both tetanus nonresponders were [HLA-B8,SC01,DR3] heterozygotes. Our results indicate that: (a) response to the HBsAg vaccine is MHC linked, and inherited in a dominant fashion; (b) an abnormal or missing immune response (Ir) gene for HBsAg is a characteristic of most examples of the extended haplotype [HLA-B8,SC01,DR3]; and (c) other haplotypes also have abnormal or missing Ir genes for HBsAg.
我们最近发现,人类对乙肝病毒表面抗原(HBsAg)疫苗的抗体反应与主要组织相容性复合体(MHC)相关。在对疫苗无反应者的研究中,我们发现,人类组织相容性白细胞抗原(HLA)蛋白纯合个体的发生率有所增加,这些个体与扩展(保守)单倍型[HLA - B8,SC01,DR3]相关。在随后的前瞻性疫苗接种试验中,我们发现,该单倍型的5名纯合个体中,没有一人产生超过1300放射免疫分析(RIA)单位的抗体(平均为467 RIA单位),而所有杂合子至少产生2500 RIA单位(平均抗体水平为15608单位)。我们的结果表明,[HLA - B8,SC01,DR3]缺乏针对HBsAg的免疫反应基因,且该反应以显性方式遗传。为了进一步证实这一假设,我们现在分析了家庭中HBsAg免疫接种的结果。10个家庭的43名成员接种了乙肝疫苗,其中7个家庭至少有一名成员携带单倍型[HLA - B8,SC01,DR3],3个家庭中有一名成员之前接种过疫苗但无反应。在这3个家庭中的2个家庭中,随后发现了[HLA - B8,SC01,DR3]。在该研究的9对MHC相同的同胞对中,8对的两名成员具有相似的抗体反应(5对无反应者和3对有反应者)。在所有有此类同胞对的家庭中,包括不一致的那一对,按抗体水平对成员进行排序表明,没有亲属的值介于同胞对的值之间。此外,在9名[HLA - B8,SC0】,DR3]单倍型纯合个体中,6名无反应者,另外2名只有低正常反应。[HLA - B8,SC01,DR3]杂合家庭成员的抗体水平总是高于其纯合亲属。对HLA单倍型无反应的连锁分析显示,在重组率为0.1时,最大似然LOD(优势对数)评分为6.3。在破伤风免疫中未发现MHC与对HBsAg缺乏抗体反应之间的关联,在20名HBsAg有反应者中有1名以及21名反应差或无反应者中有1名破伤风滴度低于1:512;两名破伤风无反应者均为[HLA - B8,SC01,DR3]杂合子。我们的结果表明:(a)对HBsAg疫苗的反应与MHC连锁,并以显性方式遗传;(b)大多数扩展单倍型[HLA - B8,SC01,DR3]的例子都具有针对HBsAg的异常或缺失的免疫反应(Ir)基因;(c)其他单倍型也有针对HBsAg的异常或缺失的Ir基因。